New pill for chronic hives enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study tests an experimental pill called EDP-978 in healthy adults to see if it is safe and how the body handles it. The drug is being developed for people with long-lasting hives. About 98 participants will receive either the drug or a placebo, and researchers wi…
Phase: PHASE1 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC